View Cart

  
Go back to: Catalog> List of Products
View Cart

Chromium (LEF-169)

$18.90

Chromium - 200 mcg - 365 Capsules
Quantity:
Chromium is an essential trace mineral that has been shown to promote cardiovascular health.96-100* Along with regular exercise, 400-600 mcg of chromium polynicotinate has been shown to support healthy weight control in overweight women.101,102*
 

References:

1. J Nutr. 1992 Mar;122(3):442-9.
2. Proc Soc Exp Biol Med. 1985 Dec;180(3):432-46.
3. Am J Clin Nutr. 1983 Jul;38(1):12-9.
4. Am J Clin Nutr. 1979 Sep;32(9):1876-80.
5. Lancet. 1973 Feb 10;1(7798):283-8.
6. N Engl J Med. 1985 Jul 11;313(2):70-3.
7. Am J Ther. 1999 Nov;6(6):313-21.
8. J Am Coll Nutr. 1990 Dec;9(6):583-7.
9. J Bone Miner Res. 1988 Jun;3(3):253-8.
10. J Clin Endocrinol Metab. 1985 Aug;61(2):391-3.
11. JAMA. 1996 Apr 3;275(13):1016-22.
12. FASEB J. 2000 Jun;14(9):1132-8.
13. J Am Coll Nutr. 2000 Nov-Dec;19(6):754-60.
14. Int J Obes Relat Metab Disord. 2001 Apr;25(4):559-66.
15. FASEB J. 2001 Feb;15(2):291-3. Epub 2000 Dec 08.
16. J Bone Miner Res. 1998 Apr;13(4):749-58.
17. Ann Pharmacother. 2002 Feb;36(2):255-60.
18. Am Heart J. 1984 Jul;108(1):188-93.
19. Angiology. 1994 Jul;45(7):637-45.
20. Nutr Rev. 1995 Sep;53(9 Pt 2):S23-7.
21. J Clin Endocrinol Metab. 1998 Aug;83(8):2742-8.
22. Am J Clin Nutr. 1991 Jan;53(1):106-11.
23. Public Health Rep. 1989 Sep-Oct;104 Suppl:46-50.
24. J Clin Endocrinol Metab. 1994 Sep;79(3):730-5.
25. Magnes Trace Elem. 1990;9(2):61-9.
26. Curr Pharm Des. 2003;9(32):2687-704.
27. Biol Trace Elem Res. 28:243-55, 1991.
28. Magnes Res. 1993 Jun;6(2):155-63.
29. J Reprod Med. 1990 May;35(5):503-7.
30. Gynecol Endocrinol. 1994 Mar;8(1):55-8.
31. Eur J Obstet Gynecol Reprod Biol. 2000 May;90(1):97-101.
32. Arch Tierernahr. 1992;42(1):25-35 (in German).
33. Sci News. 1986; Sept. 27:199
34. J Am Coll Nutr. 1993;12:384-389
35. Orhtopedics. 1974;103:212-234
36. Acta Orthop Scand. 1977 May;48(1):1-4.
37. Acta Med Scand. 1980;207(1-2):67-70.
38. J Nutr. 1994 Jul;124(7):1060-4.
39. Crit Care Nurs Q. 2004 Jan-Mar;27(1):96-100.
40. Altern Med Rev. 1999 Apr;4(2):74-85.
41. Calcif Tissue Int. 1990 May;46(5):300-4.
42. FASEB J. 1987 Nov;1(5):394-7.
43. Crit Rev Food Sci Nutr. 2003;43(2):219-31.
44. Biol Trace Elem Res. 2001 Jul;81(1):29-45.
45. Environ Health Perspect. 1994 Nov;102 Suppl 7:83-5.
46. Environ Health Perspect. 1994 Nov;102 Suppl 7:59-63.
47. Am J Clin Nutr. 2004 Aug;80(2):264-70.
48. Am J Ther. 1999 Nov;6(6):313-21.
49. J Am Coll Nutr. 1990 Dec;9(6):583-7.
50. J Bone Miner Res. 1988 Jun;3(3):253-8.
51. J Clin Endocrinol Metab. 1985 Aug;61(2):391-3.
52. Am J Gastroenterol. 1989 Feb;84(2):97-108.
53. J Nutr. 2003 Sep;133(9):2879-82.
54. Magnes Res. 2003 Sep;16(3):183-91.
55. J Am Coll Nutr. 1990 Feb;9(1):48-55.
56. Fortschr Med. 1990 Sep 30;108(28):539-42(in German).
57. Br J Nutr. 1997 Nov;78(5):737-50.
58. Acta Paediatr Taiwan. 2001 Nov-Dec;42(6):345-9.
59. J Int Med Res. 1989 Sep-Oct;17(5):442-54.
60. Fortschr Med. 1990 Sep 30;108(28):539-42.
61. J Assoc Physicians India. 2003 Jan;51:37-42.
62. Clin Cardiol. 2000 Jun;23(6):433-6.
63. Am J Cardiol. 1999 Jul 15;84(2):152-6.
64. Am J Cardiol. 2003 Mar 1;91(5):517-21.
65. Br J Nutr. 1997 Nov;78(5):737-50.
67. Magnes Res. 1993 Dec;6(4):355-60.
68. Hypertension. 1989 Mar;13(3):227-32.
69. Am J Hypertens. 1988 Jul;1(3 Pt 3):71S-74S.
70. Hypertension. 1998 Aug;32(2):260-5.
71. Health Rep. 1994;6(1):22-7.
72. J Nutr. 2003 Sep;133(9):2879-82.
73. Annu Rev Nutr. 1999;19:1-16.
74. Eur J Heart Fail. 2001 Dec;3(6):661-9.
75. J Natl Cancer Inst. 2003 Jan 15;95(2):98-100.
76. Thyroid. 2002 Oct;12(10):867-78.
77. Am J Clin Nutr. 2004 Jul;80(1):154-62.
78. Zhonghua Yu Fang Yi Xue Za Zhi. 1997 Nov;31(6):358-61 (in Chinese).
79. Tokai J Exp Clin Med. 1995 May;20(1):53-64.
80. Am J Clin Nutr. 1989 May;49(5):862-9.
81. Cancer Res. 2003 Oct 15;63(20):6988-95.
82. Carcinogenesis. 1996 Sep;17(9):1979-82.
83. J Agric Food Chem. 1995; 43:1754-1757.
84. J Nutr. 1998 Nov;128(11):1845-54.
85. Sci Total Environ. 1981 Jan;17(1):13-29.
86. 10th International Congress of Toxicology-Finland. 2004 July;197:abs. 354.
87. Molecular and Cellular Biochemistry. 252:369-377, 2003.
88. J Med. 2000;31(5-6):227-46.
89. Biol Trace Elem Res. 1996 Dec;55(3):297-305.
90. Research Communications in Pharmacology and Toxicology. 2000 5:91-108.
91. Nutrition Research. 13:239-249, 1993.
92. Diabetes Obes Metab. 1999 Nov;1(6):331-7.
93. Med Science Sports Exer. 1997; 29, 992 998.
94. J Pineal Res. 2003 May;34(4):269-77.
95. Biochem Biophys Res Commun. 2003 Oct 3;309(4):1017-26.
96. J Med. 2000;31(5-6):227-46.
97. Research Communications in Pharmacology and Toxicology. 2000 5:91-108.
98. Biol Trace Elem Res. 1996 Dec;55(3):297-305.
99. Nutrition Research. 13:239-249, 1993.
100. J Fam Pract. 1988 Dec;27(6):603-6.
101. Diabetes Obes Metab. 1999 Nov;1(6):331-7.
102. Med Science Sports Exer. 1997; 29, 992 998.
103. Magnes Res. 1999 Sep;12(3):181-9.
104. Adv Wound Care. 1999 Apr;12(3):137-8.
105. Br J Dermatol. 1999 Jan;140(1):26-34.
106. Lancet. 1996 Mar 16;347(9003):706-7.
107. Arch Emerg Med. 1992 Jun;9(2):122-4.
108. J Am Geriatr Soc. 1998 Jan;46(1):19-26.
109. J Am Coll Nutr. 1990 Jun;9(3):214-25.
110. Am J Med. 1981 May;70(5):1001-4.
111. Acta Otolaryngol Suppl. 2002;(546):129-33.
112. Cancer. 1998 May 15;82(10):1938-45.
113. Nippon Jibiinkoka Gakkai Kaiho. 1995 Jul;98(7):1135-9 (in Japanese).
114. Ann Intern Med. 1969 Oct;71(4):791-821.
115. Proc Natl Acad Sci USA. 1969 Jan;62(1):30-7.
116. J Nutr. 2000 May;130(5S Suppl):1437S-46S.
117. Metabolism. 2004 Jun;53(6):727-32.
118. Biol Trace Elem Res. 1992 Jan-Mar;32:305-10.
119. Fertil Steril. 1999 Jun;71(6):1138-43.
120. Urology. 1979 Mar;13(3):280-1.
121. Clin Chim Acta. 1976 Jul 1;70(1):123-6.
122. Am J Clin Nutr. 1985 Feb;41(2):285-92.
123. JAMA. 1984 Sep 21;252(11):1443-6.
124. J Anim Sci. 1992 Jan;70(1):178-87.
125. Ann Intern Med. 1996 Jul 15;125(2):81-8.
126. Chemother. 1984 Jan;25(1):20-4.
127. Dan Med Bull. 1990 Jun;37(3):279-81.
128. JAMA. 1998 Jun 24;279(24):1962-7.
129. J Antimicrob Chemother. 1987 Dec;20(6):893-901.
130. Am J Ther. 2002 Nov-Dec;9(6):472-5.
131. Clin Infect Dis. 2000 Nov;31(5):1202-8.
132. J Int Med Res. 1992 Jun;20(3):234-46.
133. Antimicrob Agents Chemother. 1987 Aug;31(8):1183-7.
134. Adv Ther. 2002 May-Jun;19(3):151-9.
135. Int J Clin Pharmacol Ther. 1998 Jun;36(6):320-5.
136. Int J Clin Pharmacol Ther Toxicol. 1993 Apr;31(4):157-69.
137. Int J Clin Pharmacol Ther Toxicol. 1993 Mar;31(3):103-23.
138. J Int Med Res. 1987 Nov-Dec;15(6):379-82.
139. Int J Clin Pharmacol Ther Toxicol. 1993 Jan;31(1):40-51
140. J Bone Miner Res. 2004 Feb;19(2):297-307.
141. Occup Ther Int. 2002;9(2):121-30.
142. J Nutr Health Aging. 2002;6(2):154-62.
143. Am J Clin Nutr. 2002 May;75(5):887-93.
144. FASEB J. 1991 Sep;5(12):2661-7.
145. Sci Total Environ. 1988 Jul 1;73(1-2):95-106.
146. Nutr Rev. 1982 Jul;40(7):193-8.
147. Biol Trace Elem Res. 1991 Dec;31(3):235-47.
148. Atherosclerosis. 1979 Aug;33(4):397-408.
149. Lancet. 1977 Feb 26;1(8009):454-7.
150. Calcif Tissue Int. 2000 Jan;66(1):53-5.
151. Tissue Int. 1981;33(1):27-34.
152. Anon. Silica. Dec95, Vol. 57 Issue 12, p30, 1p, 1c
153. Am J Clin Nutr. 1995 Feb;61(2):341-5.
154. Environ Health Perspect. 1994 Nov;102 Suppl 7:83-5.
155. J Trace Elem Exp Med. 1990;3:45-54.
157. FASEB J. 1987 Nov;1(5):394-7.
158. Am J Clin Nutr. 1998 May;67(5 Suppl):1091S-1097S.
159. Am J Clin Nutr. 1985 Aug;42(2):242-51.
160. Am J Clin Nutr. 1998 May;67 (5 Suppl): 1035S-1040S.
161. J Am Coll Nutr. 1985;4(1):83-105.
162. Am J Clin Nutr. 1982 Apr;35(4):809-14.
163. Am J Clin Nutr. 1996 May;63(5):791S-6S.
164. Int J Sport Nutr Exerc Metab. 2002 Dec;12(4):470-9.
165. J Clin Endocrinol Metab. 2001 Mar;86(3):1410-7.
166. Metabolism. 2000 Mar;49(3):400-10.
167. Metabolism. 1996 Sep;45(9):1130-5.
168. Diabetes. 1996 May;45(5):659-66.
169. J Clin Invest. 1995 Jun;95(6):2501-9.

 
Supplement Facts
Serving Size 1 capsule
Servings Per Container 365
Amount Per Serving
Niacin (as flush free inositol hexanicotinate)
 		 30 mg
Chromium (as chromium polynicotinate)
 		 200 mcg
Inositol (as inositol hexanicotinate) 7.5 mg
Other ingredients: rice flour, gelatin and water.
This product contains NO sugar, yeast, wheat, gluten, corn or dairy. Contains NO artificial color, sweeteners, flavors or preservatives.

ChromeMate® a patented, biologically active oxygen-coordinated niacin-bound chromium complex, is a trademark of InterHealth Nutritionals Inc., U.S. Patents No. 4,923,855; 4,954,492; 5,194,615.
Dosage and Use
One to two capsules daily is suggested.
This product is best utilized when taken with meals.
Caution
People suffering from hepatitis or any type of liver damage may want to avoid niacin. Check with your physician before taking this product.
Niacin may also irritate the stomach. Niacin is acidic and may require a buffering agent to be coingested if its acidity is unacceptable.
When taking niacin methylating factors such as folic acid, vitamin B12, choline and TMG should be part of one’s supplement program to protect the liver.
When used in large doses (greater than 500 mg per day) hepatotoxicity may occur, especially if preparation is sustained release. Monitor liver function tests.*
Warnings
 

None of the statements on this website have been evaluated by the FDA. These products are not intended to diagnose, treat, cure or prevent any disease. Research is ongoing.

All Contents Copyright © 2000-2008 Alethos Consulting, LLC dba LifeXT.com All rights reserved.

The information provided on this site is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional or any information contained on or in any product label or packaging. You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. You should consult with a healthcare professional before starting any diet, exercise or supplementation program, before taking any medication, or if you have or suspect you might have a health problem. You should not stop taking any medication without first consulting your physician.